The goal is not athletic performance
A low result is obviously a big red flag, but it's crucial to know that this test alone doesn't always tell the whole story
Always discuss significant dietary or lifestyle changes with your healthcare team, particularly if you have existing medical conditions or take regular medications
The MHRA has approved various GLP-1 agonists for specific indications, with NICE providing guidance on their use in type 2 diabetes (NG28) and weight management (TA875 for semaglutide/Wegovy, TA664 for liraglutide/Saxenda)
Ipamorelin peptide Canada from Maple Research Labs delivers 5mg of high-purity growth hormone secretagogue for qualified research applications
*Correspondence: Qianyan Wang [email protected] Zhang [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers